Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. quarterly report Koblenz (euro adhoc) - August 12, 2010: CompuGroup Medical AG today presented the financial report for the second quarter of 2010. The company, one of the leading global providers of eHealth solutions, achieved revenue of EUR 76.7 million, up from EUR 75.1 million in ...
Wokingham, England, July 22, 2010 (ots/PRNewswire) - Kowa are delighted to announce that following the completion of the decentralized regulatory procedure, that their statin, pitavastatin has achieved a positive outcome from the UK Regulatory Authority (MHRA) acting as the Reference Member State for 16 EU countries. Pitavastatin is indicated for the reduction ...
Basel, Switzerland, July 21, 2010 (ots/PRNewswire) - New data show that Avastin(R) (bevacizumab) based therapy provides a median overall survival (OS) of 14.6 months with a range of chemotherapies routinely used in clinical practice and in a broad population of patients with advanced non-small cell lung cancer ...
Zürich (ots) - The Jacobs Foundation's Board of Trustees has appointed Dr. Auma Obama as a new member. Auma Obama works as a Global Technical Advisor for the aid organisation "CARE International" and - like the Jacobs Foundation - actively promotes educational and development opportunities for young people. The Jacobs Foundation, with its registered office in ...
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/Disclosure of equity participations 08.07.2010 Henderson Global Investors take significant stake in LifeWatch AG Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss ...
Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Study to include healthy volunteers and diabetic patients Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Subtitle: Study to include healthy volunteers and diabetic patients Berlin, Germany, 7 July 2010 (euro ...
Munich, June 28, 2010 (ots/PRNewswire) - Interim data from a prospective Investigator Initiated Trial (IIT) presented today at the ECTS, the 37th European Symposium on Calcified Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg; once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated ...
Hamburg and Calgary, Canada, June 22, 2010 (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announced today that key scientific data was communicated in an oral presentation highlighting the novel features of the Company's lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) conference being held in Hamburg, Germany. The presentation titled "RVX-208 given orally raises ...
Quebec, Canada, June 14, 2010 (ots/PRNewswire) - Obzerv Technologies Inc. today announces the commercial availability of a Modular Active Range-Gated Camera. Airborne Multi-Spectral Imaging Turrets manufacturers around the world are constantly increasing the number of sensors available as well as their ...
- Capacity expansion in important growth market - Intensification of alliance with Lanxess AG Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Subtitle: - Capacity expansion in important growth market - ...
90 innovations for greater safety and functionality Five individual vehicle concepts to be showcased at the INTERSCHUTZ Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products Subtitle: 90 ...
Atrium European Real Estate Limited
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 04.06.2010 Atrium European Real Estate Limited announces adjournment of Noteholders Meeting and Extension of Tender Offer in relation to its E600,000,000 5.375 per cent. Guaranteed Notes due 2013 NOT ...
Huntington Beach, California and Amsterdam, June 4, 2010 (ots/PRNewswire) -- Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), ...
Rosenbauer conquers French airports Multi-year major order placed by Aéroports de Paris Supply of up to 20 PANTHER 8x8 for Charles de Gaulle and Orly airports Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Contracts Subtitle: Rosenbauer conquers French airports Multi-year major order placed by Aéroports de Paris ...
Geneva (ots) - PEARL I trial meets primary efficacy and safety endpoints / PregLem preparing for submission to the European Medicines Agency in 2010 PregLem, the European specialty biopharmaceutical company focused on women's reproductive medicine, announces positive Phase III data from its second pivotal study (PEARL I) for its lead product Esmya (ulipristal acetate), as an effective treatment for uterine ...
London, May 24, 2010 (ots/PRNewswire) - The World Gold Council (WGC) today announced the appointment of David Lamb as its Managing Director, Jewellery, to be effective 1 July 2010. Mr. Lamb, who will be based in New York, will have overall responsibility for the strategic development of the gold jewellery market worldwide with a particular focus in building the ...
The Hague, The Netherlands, May 4, 2010 (ots/PRNewswire) - Shell's largest integrated refinery and petrochemicals complex is now fully online. The multi-billion dollar project in Singapore boosts the supply of raw materials for many everyday products and uses ultra-efficient Shell technology. The site is already supplying products to Asian growth markets and to manufacturers in Singapore. It is a cornerstone of ...
Deutsche Effecten- und Wechsel-Beteiligungsges. AG
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Company Information Berlin, Germany, May 03, 2010 (euro adhoc) - NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique ...
SCHOELLER-BLECKMANN OILFIELD EQUIPMENT Aktiengesellschaft
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Buybacks Ternitz (euro adhoc) - SHARE BUYBACK PROGRAM SCHOELLER-BLECKMANN OILFIELD EQUIPMENT Aktiengesellschaft Publication in accordance with § 7 para 4 and § 7 para 2 L. 1 to ...
Atrium European Real Estate Limited
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 29.04.2010 Atrium European Real Estate Limited announces Tender Offer and Proposal for its EUR600,000,000 5.375 per cent. Guaranteed Notes due ...
MPC Münchmeyer Petersen Capital AG
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Share Pooling Agreement 16.04.2010 Hamburg, April 16th, 2010, MPC Münchmeyer Petersen & Co. GmbH ("MPC Holding") and Corsair III Investment (Luxembourg) S. à. r. ...
Brussels, Belgium, March 19, 2010 (ots/PRNewswire) - Patients with neurological diseases need more help with their associated sleep-wake disturbances that can often make their underlying illness worse, say leading sleep specialists attending a sleep meeting hosted by biopharmaceutical company, UCB, to mark World ...
Reading, England, March 2, 2010 (ots/PRNewswire) - Archimedes Pharma ("Archimedes"), the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also ...
Paris/Lausanne (ots) - Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss- based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce ...
Agence de Medecine Preventive (AMP)
Paris (ots/PRNewswire) - On January 15, the Minister of Health and Hygiene of Côte d'Ivoire, Dr. Rémi Allah Kouadio, presided over a ceremony to mark the launch of a National Immunization Technical Advisory Group (NITAG) named "Côte d'Ivoire National Committee of Independent Experts for Vaccination and Vaccines" (Comité National d'Experts Indépendants pour la ...
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. New Products Dornbirn (euro adhoc) - Press Release Dornbirn, 22 January 2010 LEDON Lamp: Zumtobel Group enters the LED lamp business LEDON Lamp GmbH founded as sales company for LED lamps LED technology "made in Austria" by ...
Charlotte, North Carolina (ots/PRNewswire) - Bank of America Corporation today reported full-year 2009 net income of US$6.3 billion, compared with net income of US$4.0 billion in 2008. Including preferred stock dividends and the negative impact from the repayment of the U.S. government's US$45 billion preferred stock investment in the company under the Troubled Asset Relief Program (TARP), income applicable to common ...
Atrium European Real Estate Limited
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. 07.01.2010 Tender Offer for up to EUR120,000,000 of EUR600,000,000 5.375 per cent. Guaranteed Notes due 2013 NOT FOR DISTRIBUTION IN OR INTO OR TO ...
Calgary, Canada (ots/PRNewswire) - Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD). This study is chaired by Dr. Steven Nissen, MD, Chairman ...
Saint-Prex, Switzerland (ots) - Results from a phase III pivotal study sub-analyses reported in European Urology show that prostate cancer patients who received Firmagon® (degarelix) in the study have a statistically significant greater probability of PSA (prostate-specific-antigen) recurrence-free survival ...